210 related articles for article (PubMed ID: 18053049)
1. Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study.
Salti G; Ghersetich I; Tantussi F; Bovani B; Lotti T
Dermatol Surg; 2008 Jan; 34(1):60-6; discussion 66. PubMed ID: 18053049
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat.
Rotunda AM; Weiss SR; Rivkin LS
Dermatol Surg; 2009 May; 35(5):792-803. PubMed ID: 19397673
[TBL] [Abstract][Full Text] [Related]
3. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution.
Rotunda AM; Suzuki H; Moy RL; Kolodney MS
Dermatol Surg; 2004 Jul; 30(7):1001-8. PubMed ID: 15209790
[TBL] [Abstract][Full Text] [Related]
4. Action of sodium deoxycholate on subcutaneous human tissue: local and systemic effects.
Yagima Odo ME; Cucé LC; Odo LM; Natrielli A
Dermatol Surg; 2007 Feb; 33(2):178-88; discussion 188-9. PubMed ID: 17300603
[TBL] [Abstract][Full Text] [Related]
5. Induction of fat cell necrosis in human fat tissue after treatment with phosphatidylcholine and deoxycholate.
Bechara FG; Mannherz HG; Jacob M; Mazur AJ; Sand M; Altmeyer P; Hoffmann K
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):180-5. PubMed ID: 22280507
[TBL] [Abstract][Full Text] [Related]
6. Fat reduction using phosphatidylcholine/sodium deoxycholate injections: standard of practice.
Duncan DI; Palmer M
Aesthetic Plast Surg; 2008 Nov; 32(6):858-72. PubMed ID: 18612680
[TBL] [Abstract][Full Text] [Related]
7. Effects of phosphatidylcholine and sodium deoxycholate on human primary adipocytes and fresh human adipose tissue.
Palumbo P; Melchiorre E; La Torre C; Miconi G; Cinque B; Marchesani G; Zoccali G; Maione M; Macchiarelli G; Vitale AR; Leocata P; Cifone MG; Giuliani M
Int J Immunopathol Pharmacol; 2010; 23(2):481-9. PubMed ID: 20646343
[TBL] [Abstract][Full Text] [Related]
8. Actions and comparative efficacy of phosphatidylcholine formulation and isolated sodium deoxycholate for different cell types.
Gupta A; Lobocki C; Singh S; Robertson M; Akadiri OA; Malhotra G; Jackson IT
Aesthetic Plast Surg; 2009 May; 33(3):346-52. PubMed ID: 19198927
[TBL] [Abstract][Full Text] [Related]
9. Cytokine mRNA levels in human fat tissue after injection lipolysis with phosphatidylcholine and deoxycholate.
Bechara FG; Skrygan M; Kreuter A; Altmeyer P; Gambichler T
Arch Dermatol Res; 2008 Sep; 300(8):455-9. PubMed ID: 18563422
[TBL] [Abstract][Full Text] [Related]
10. Mesotherapy and phosphatidylcholine injections: historical clarification and review.
Rotunda AM; Kolodney MS
Dermatol Surg; 2006 Apr; 32(4):465-80. PubMed ID: 16681654
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial.
Reeds DN; Mohammed BS; Klein S; Boswell CB; Young VL
Aesthet Surg J; 2013 Mar; 33(3):400-8. PubMed ID: 23439063
[TBL] [Abstract][Full Text] [Related]
12. Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer.
Schuller-Petrovic S; Wölkart G; Höfler G; Neuhold N; Freisinger F; Brunner F
Dermatol Surg; 2008 Apr; 34(4):529-42; discussion 542-3. PubMed ID: 18370980
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness and safety of topical PhotoActif phosphatidylcholine-based anti-cellulite gel and LED (red and near-infrared) light on Grade II-III thigh cellulite: a randomized, double-blinded study.
Sasaki GH; Oberg K; Tucker B; Gaston M
J Cosmet Laser Ther; 2007 Jun; 9(2):87-96. PubMed ID: 17558758
[TBL] [Abstract][Full Text] [Related]
14. Histological changes associated with mesotherapy for fat dissolution.
Rose PT; Morgan M
J Cosmet Laser Ther; 2005 Mar; 7(1):17-9. PubMed ID: 16020211
[TBL] [Abstract][Full Text] [Related]
15. Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate.
Park EJ; Kim HS; Kim M; Oh HJ
J Cosmet Dermatol; 2013 Sep; 12(3):240-3. PubMed ID: 23992167
[TBL] [Abstract][Full Text] [Related]
16. Lipomas treated with subcutaneous deoxycholate injections.
Rotunda AM; Ablon G; Kolodney MS
J Am Acad Dermatol; 2005 Dec; 53(6):973-8. PubMed ID: 16310057
[TBL] [Abstract][Full Text] [Related]
17. Injection lipolysis for reduction of saddlebag trochanteric bulges--half-side controlled pilot study.
Kopera D; Horejsi R; Werner S; Moeller R
J Dtsch Dermatol Ges; 2008 Apr; 6(4):287-90. PubMed ID: 18081857
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis or lipid dissolution?
Klein SM; Schreml S; Nerlich M; Prantl L
Plast Reconstr Surg; 2009 Aug; 124(2):419-427. PubMed ID: 19644256
[TBL] [Abstract][Full Text] [Related]
19. Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study.
Co AC; Abad-Casintahan MF; Espinoza-Thaebtharm A
J Cosmet Dermatol; 2007 Dec; 6(4):250-7. PubMed ID: 18047610
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylcholine in the treatment of localized fat.
Hexsel D; Serra M; Mazzuco R; Dal'Forno T; Zechmeister D
J Drugs Dermatol; 2003 Oct; 2(5):511-8. PubMed ID: 14558399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
